Generation of Potent T-Cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-15-0054
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer

American Journal of Hematology
Hematology
2019English

Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy

JAMA Oncology
Cancer ResearchOncology
2018English

IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2015English

Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

Chimeric Antigen Receptor T-Cell Immunotherapy for Glioblastoma: Practical Insights for Neurosurgeons

Neurosurgical Focus
MedicineSurgeryNeurology
2018English

Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2012English

Characterization of Human Prostate and Breast Cancer Cell Lines for Experimental T Cell-Based Immunotherapy

Prostate
OncologyUrology
2007English

Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma

Annals of Hematology
MedicineHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy